Alnis Biosciences Inc is categorized under Research and Development Laboratories in Durham, NC and active since 1997.
Alnis Biosciences Inc was established in 1997, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Research and Development Laboratories business, which does work in the B2B market, and is classified as a Research and Development Laboratories, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Steve Barry at the company’s single location by writing to 21 Davis Drive, Durham, North Carolina NC 27709 or by phoning (919) 597-6137. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Alnis Biosciences Inc |
| Contact Person: | Steve Barry |
| Address: | 21 Davis Drive, Durham, North Carolina 27709 |
| Phone Number: | (919) 597-6137 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 1997 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Research and Development Laboratories |
| SIC Code: | 8731 |
| NAICS Code: | 541712 |
| Share This Business: |
Alnis Biosciences Inc was started in 1997 to provide professional Research and Development Laboratories under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Steve Barry for inquiries that concern Alnis Biosciences Inc by calling the company number (919) 597-6137, as your correspondence is most welcome. Additionally, the physical location of the single location of Alnis Biosciences Inc can be found at the coordinates 35.892018,-78.861153 as well as the street address 21 Davis Drive in Durham, North Carolina 27709.
For its online presence, you may visit Alnis Biosciences Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.